Traws Pharma, Inc. — Director's Dealing 2015

Apr 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-04-16

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-16	Stock Option (right to buy)	$2.32	A	87500	Acquired	2025-04-16	Common Stock (87500)	Direct

Footnotes

F1: These options vest over 4 years in 48 equal monthly installments.